Header cover image

Polish Pharmaceuticals & Biotech Sustainable Track Record

Results

2

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

2 companies

Genomed Spólka Akcyjna

Market Cap: zł33.0m

Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

GEN

zł25.60

7D

-0.8%

1Y

-1.5%

Tecnovatica

Market Cap: zł5.6m

Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.

TEC

zł0.52

7D

-17.5%

1Y

50.3%